March 13, 2018
Illumina Inc. urged the Federal Circuit to pass on Ariosa Diagnostics Inc.'s bid for a rehearing of an affirmed Patent Trial and Appeal Board decision in the companies' long-running feud over prenatal testing technology, arguing there was nothing "exceptionally important" about the panel's ruling.
February 27, 2018
The Electronic Frontier Foundation has thrown its support behind Ariosa Diagnostics Inc.'s request for a full Federal Circuit rehearing of an affirmed Patent Trial and Appeal Board decision the nonprofit argues is contrary to both the Patent Act and public policy.
December 11, 2017
The Federal Circuit on Monday said it does not have the power to review Patent Trial and Appeal Board decisions to terminate patent re-examinations in a short order refusing to revive a challenge to an Illumina Inc. diagnostic patent.